47. Buerger disease Clinical trials / Disease details


Clinical trials : 9 Drugs : 14 - (DrugBank : 7) / Drug target genes : 5 - Drug target pathways : 16

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05698979
(ClinicalTrials.gov)
January 30, 20235/1/2023Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's DiseaseEvaluation of Botulinum TOXin Type A in the Treatment of Buerger's DiseaseBuerger Disease;Raynaud SyndromeDrug: BOTOX INJECTIONUniversity Hospital, ToulouseNULLNot yet recruiting18 YearsN/AAll8Phase 3NULL